| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1255764B1 Purine derivatives |
| 05/10/2006 | EP1224205B1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | EP1047423B1 Novel apoptosis inhibitors |
| 05/10/2006 | CN1771244A Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 05/10/2006 | CN1771228A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof. |
| 05/10/2006 | CN1771039A Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 05/10/2006 | CN1771030A Methods for treatment of parkinson's disease |
| 05/10/2006 | CN1771029A Combination of desoxypeganine and mecamylamine for the treatment of alcohol abuse |
| 05/10/2006 | CN1769276A Benzothiadiazine derivatives, process of preparation thereof and pharmaceutical compositions containing them |
| 05/10/2006 | CN1768861A Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 05/10/2006 | CN1768850A Medicinal composition for get rid of opium drug dependence |
| 05/10/2006 | CN1768783A Safflower and salvanobi acid formulation and preparation method thereof |
| 05/10/2006 | CN1768779A Soft capsule of'Yu Feng Ning Xin' and preparation thereof |
| 05/10/2006 | CN1768777A Compound formulation of astragalus root for treating cardiovascular and cerebrovascular diseases, its preparing process and application |
| 05/10/2006 | CN1768770A Quality control method of agavaceae extract medicinal formulation |
| 05/10/2006 | CN1768767A Spleen-benefiting mind-tranquilizing formulation and its production method |
| 05/10/2006 | CN1768762A Novel drug administering route of pantocrine injection, its preparation process and novel indications |
| 05/10/2006 | CN1768760A Medicinal composition containing safflower total flavone and its preparation process and usage |
| 05/10/2006 | CN1768746A Novel medical use of matrine alkaloid |
| 05/10/2006 | CN1768740A Medicinal composition containing carthamin yellow and its preparation process and usage |
| 05/10/2006 | CN1768735A Medicaments for diabetic complication and neuropathy, and uses thereof |
| 05/10/2006 | CN1768734A Sodium ferulate glucose infusion liquid and its preparation method |
| 05/10/2006 | CN1768587A Health-caring fleece-flower root tea |
| 05/10/2006 | CN1255522C Aqueous extract of irid and usage |
| 05/10/2006 | CN1255413C (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator |
| 05/10/2006 | CN1255407C Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines |
| 05/10/2006 | CN1255406C Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods |
| 05/10/2006 | CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 05/10/2006 | CN1255389C Morpholol with medicinal activity |
| 05/10/2006 | CN1255382C Modulators of dopamine neurotransmission |
| 05/10/2006 | CN1255169C Medicine for relaxing muscles and tendons and activating collaterals and dispelling pain |
| 05/10/2006 | CN1255163C Ganoderma lucidum tea for healthy vital spark and preparation method |
| 05/10/2006 | CN1255157C Preparation of Chinese traditional medicine for enhancing and consolidating memory |
| 05/10/2006 | CN1255105C Water soluble dressing materials of ziracitone and its salts and their preparation |
| 05/10/2006 | CN1255103C Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof |
| 05/10/2006 | CN1255100C Soft capsule preparation of Tibet medicine 'unique taste' and preparation method thereof |
| 05/10/2006 | CN1255049C Functional agent for decomposing nicotine and method of preparing the same |
| 05/09/2006 | US7041835 (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 05/09/2006 | US7041834 alkylamination of N-methylcarbazol-5-one at the 6-position in the presence of formaldehyde, a secondary amine, and a desiccant; deamination and coupling of 2-methylimidazole at the 1-position; reaction time less than three hours |
| 05/09/2006 | US7041829 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 05/09/2006 | US7041828 Phenyl-substituted imidazopyridines |
| 05/09/2006 | US7041827 Phenyl-substituted imidazopyridines |
| 05/09/2006 | US7041806 Netrin receptors |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041794 Nucleotide sequence comprises at least one new SNP (single nucleotide polymorphism) |
| 05/09/2006 | US7041703 Particularly septic shock and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained |
| 05/09/2006 | US7041697 for the treatment of depression, anxiety, panic disorder, post-traumatic stress disorder, premenstrual disorder, attention deficit disorder, obsessive compulsive disorder, obesity, eating disorders, cocaine and alcohol addiction, sexual dysfunction |
| 05/09/2006 | US7041695 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 05/09/2006 | US7041689 Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase |
| 05/09/2006 | US7041688 Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's disease |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041684 4-[2-Hydroxy-3-([4-(5-carbamoyl-2-pyridyloxy)phenyl]-2-methylpropylamino)propoxy]carbazole and salts;treating obesity; antidiabetic agent for non-insulin dependent diabetes (Type II); |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041681 Nitrogen heterocyclic compounds, e.g., 3-(2-oxo-2-phenyl-ethylcarbamoyl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester; treating pain and gastrointestinal disorders. |
| 05/09/2006 | US7041673 Ultrashort acting hypnotic barbiturates |
| 05/09/2006 | US7041671 N-(1-ethylpropyl)- or N-(1-methylpropyl)-7-(6-methoxy-2-methylpyridin-3-yl)-2,6-dimethylpyrrolo[1,2-b]pyridazin-4-amine or their salts, used for treating disorders manifesting hypersecretion of CRF receptors, such as anxiety, and depression. |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041666 Adenosine A2a receptor antagonists |
| 05/09/2006 | US7041665 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 05/09/2006 | US7041664 e.g., (S)-N-(1-phenylpropyl)-2-(pyrrolidin-1-yl)-quinoline-4-carboxamide in a container with instructions for treating anxiety, depression, schizophrenia, obesity, chronic pulmonary obstructive disorder, or pain |
| 05/09/2006 | US7041662 Substituted benzo [b] azepin-2-one compounds |
| 05/09/2006 | US7041661 Use of thiazolobenzoheterocycles for treating multiple sclerosis |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/09/2006 | US7041494 DNA encoding Slo2 and Slo4, potassium channel |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041314 GPE analogs and peptidominetics |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2322501C Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 05/09/2006 | CA2238430C Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 05/04/2006 | WO2006047756A2 Substituted tetracycline compounds |
| 05/04/2006 | WO2006047687A2 Compositions and methods for short interfering nucleic acid inhibition of nav1.8 |
| 05/04/2006 | WO2006047671A2 4-aminotetracyclines and methods of use thereof |
| 05/04/2006 | WO2006047288A2 Asymmetric synthesis of dihydrobenzofuran derivatives |
| 05/04/2006 | WO2006047228A1 Asymmetric synthesis of substituted dihydrobenzofurans |
| 05/04/2006 | WO2006047124A1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor |
| 05/04/2006 | WO2006046933A1 Sedative and spasmolytic medicinal agent and method for the production thereof (variants) |
| 05/04/2006 | WO2006046910A1 Novel use |
| 05/04/2006 | WO2006046778A1 3-carbamoyl-2-pyridone derivative |
| 05/04/2006 | WO2006046575A1 Amorphous object of cinnamide compound |
| 05/04/2006 | WO2006046569A1 Neuronal differentiation promoting peptide |
| 05/04/2006 | WO2006046557A1 Abnormal protein removing composition |
| 05/04/2006 | WO2006046492A1 Novel ppar regulating agent and method of screening the same |
| 05/04/2006 | WO2006046105A1 Oxcarbazepine dosage forms |
| 05/04/2006 | WO2006046041A1 New pharmaceutical formulations useful in the treatment of insomnia |
| 05/04/2006 | WO2006045716A1 Novel diazabicyclic aryl derivatives and their medical use |
| 05/04/2006 | WO2006045554A1 (biphenyl) carboxylic acids and derivatives thereof |
| 05/04/2006 | WO2006045429A1 Halogen substituted benzodiazepine derivatives |
| 05/04/2006 | WO2006023630A3 The use of n-aryl diazaspiracyclic compounds in the treatment of addiction |
| 05/04/2006 | WO2005123718A3 Benzimidazolone carboxylic acid derivatives |
| 05/04/2006 | WO2005109987A3 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 05/04/2006 | WO2004099214A8 Quinoline 3-amino chroman derivatives |
| 05/04/2006 | US20060094788 Prostaglandin derivatives |
| 05/04/2006 | US20060094783 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 05/04/2006 | US20060094765 Use of a sri and vitamin b6 for the treatment of neurological and mental disorders |
| 05/04/2006 | US20060094759 1-methyl-3-ethoxymethyl-4-(3,4-dichlorophenyl)-piperidine; nervous system disorders |